Company intelligence / Profile preview

Slim Well

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

Slimwell is a telehealth and healthcare technology company focused on providing medical weight loss solutions through a digital platform. The company connects patients with licensed healthcare providers who prescribe GLP-1 receptor agonists, such as semaglutide and tirzepatide, for chronic weight management. Slimwell's service model includes virtual medical consultations, personalized treatment plans, and the direct shipment of medications to patients' homes. By leveraging telehealth, the company aims to improve access to metabolic health treatments and provide ongoing clinical support for individuals struggling with obesity.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Peptides
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Slim Well.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slim Well.

Explore the full profile